Business Hexo refreshes board, reaches deal with activist shareholder 7 new board members will stand for election at a meeting March 8 Nick LabaFebruary 22, 2022
Business Annual sales fall 6% to $43.1M for Aleafia The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales Nick LabaFebruary 15, 2022
Business Hexo suggests share consolidation to stay on Nasdaq A special shareholder meeting is slated for March 8 Nick LabaFebruary 15, 2022
Business Flat sales, $75M net loss for Aurora in Q2 With adult-use sales halved from a year ago, the large majority of the firm's sales now come from international medical markets Nick LabaFebruary 10, 2022
Business Neptune reports Q3 revenue up 17% to $18.4M, net loss of $21M Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories Nick LabaFebruary 10, 2022
Business Canopy’s recreational pot sales drop 18% in Q3 But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising Nick LabaFebruary 9, 2022
Business Israel-based InterCure previews record sales of $31M The firm says it commands 30% of the country's medical cannabis market Nick LabaFebruary 8, 2022
Business Nextleaf ups annual sales to $3.4M but cash reserves run low In December, the firm finished a public offering for proceeds of $3.2 million Nick LabaFebruary 3, 2022
Business High Tide posts audited financials after delay After being hit with impairment charges, the firm posted a Q4 net loss of $4.2M Nick LabaFebruary 2, 2022
Business High Tide pushes annual sales up 118% to $181.1M in fiscal 2021 Due to 'personnel challenges' the firm has yet to finalize its income tax provision, but expects to do so on or by Jan. 31 Nick LabaJanuary 27, 2022